Navigation Links
Wyeth Receives Approvable Letter from FDA for Bazedoxifene for the Prevention of Postmenopausal Osteoporosis
Date:12/24/2007

ducts (including that there can be no assurance that our pending NDAs for bazedoxifene will be approved or that the product will ever be successfully commercialized); government cost-containment initiatives; restrictions on third-party payments for our products; substantial competition in our industry, including from branded and generic products; data generated on our products; the importance of strong performance from our principal products and our anticipated new product introductions; the highly regulated nature of our business; product liability, intellectual property and other litigation risks and environmental liabilities; uncertainty regarding our intellectual property rights and those of others; difficulties associated with, and regulatory compliance with respect to, manufacturing of our products; risks associated with our strategic relationships; economic conditions including interest and currency exchange rate fluctuations; changes in generally accepted accounting principles; trade buying patterns; the impact of legislation and regulatory compliance; risks and uncertainties associated with global operations and sales; and other risks and uncertainties, including those detailed from time to time in our periodic reports filed with the Securities and Exchange Commission, including our current reports on Form 8-K, quarterly reports on Form 10-Q and annual report on Form 10-K, particularly the discussion under the caption "Item 1A, Risk Factors." The forward-looking statements in this press release are qualified by these risk factors. We assume no obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise.


'/>"/>
SOURCE Wyeth Pharmaceuticals
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Wyeth and Nycomed Announce Court Denial of Preliminary Injunction
2. Wyeths Pearl River, N.Y. Facility Celebrates 100 Years of Achievements in Health care
3. Wyeth Announces Election of Bernard Poussot as CEO of Company Effective January 1, 2008
4. Wyeth Announces the Election of Robert M. Amen to Its Board of Directors
5. Wyeth Comments on PREVNAR and Trends in Pneumococcal Disease
6. Wyeth to Appeal Nevada Hormone Therapy Trial Verdict
7. Wyeth Reports Earnings Results for the 2007 Third Quarter and First Nine Months
8. Wyeth Consumer Healthcare Initiates Voluntary Recall and Replacement Program for Several Robitussin Products and Childrens Dimetapp Cold & Chest Congestion
9. Wyeth Consumer Healthcare Announces the Availability of Centrum Cardio and New Formula Centrum Products
10. Wyeth to Present at the Credit Suisse First Boston Healthcare Conference
11. Wyeth Receives FDA Approval of Protonix for Delayed-Release Oral Suspension
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... Lake City, UT (PRWEB) July 25, 2014 ... basketball court surfaces for the recent Nike National ... and the current United States Junior National Tournament ... through July 25. , The flooring for these prestigious ... totaling more than 300,000 square feet of playing surface ...
(Date:7/25/2014)... 25, 2014 Florida Hospital and MOSI officially ... organizations for years to come and make a difference in ... $2 million dollar check to provide the support needed to ... enable MOSI to transform the IMAX Dome Theatre from film ... the only IMAX Dome Theatre in the state of Florida, ...
(Date:7/25/2014)... AttorneyOne.com, a recognized authority on law, update the website ... Ibuprofen and Oxcarbazepine Tablets . , The FDA ... one lot of Oxcarbazepine Tablets, by American Health Packaging (AHP), ... used for the treatment of certain types of seizures in ... recall is that Lot #142588, Expiration Date, 01/2016 of Ibuprofen ...
(Date:7/25/2014)... 2014 A new study of participants in ... are published today in Cancer , found evidence that ... who had an abnormal finding on a lung cancer screening ... life than did those who were screened and found to ... to the researchers. “We expected that participants with an abnormal ...
(Date:7/25/2014)... This is a professional and ... Galactooligosaccharides (GOS) industry in Global and China. ... industry, including definitions, applications and industry chain structure. ... are provided with a focus on history, developments, ... comparison between the international and Chinese situation is ...
Breaking Medicine News(10 mins):Health News:Sport Court Provides All Sports Flooring for Basketball Events in Chicago and Washington D.C. 2Health News:Florida Hospital Donates a Two Million Dollar Transformational Gift to the Museum of Science and Industry (MOSI) 2Health News:Florida Hospital Donates a Two Million Dollar Transformational Gift to the Museum of Science and Industry (MOSI) 3Health News:Florida Hospital Donates a Two Million Dollar Transformational Gift to the Museum of Science and Industry (MOSI) 4Health News:Ibuprofen and Oxcarbazepine Tablets Recalled: AttorneyOne Monitors and Keep Consumers Informed 2Health News:Full Explanation Reduces Seniors’ Worries about Lung Cancer Screening 2Health News:Full Explanation Reduces Seniors’ Worries about Lung Cancer Screening 3Health News:Full Explanation Reduces Seniors’ Worries about Lung Cancer Screening 4Health News:Full Explanation Reduces Seniors’ Worries about Lung Cancer Screening 5Health News:GOS Market (Galacto-oligosaccharides) Development in Global & China Regions Now Available at DeepResearchReports.com 2Health News:GOS Market (Galacto-oligosaccharides) Development in Global & China Regions Now Available at DeepResearchReports.com 3
... , TIANJIN, China, June 3 ... by Pfizer Inc. as the 2008 Top Intermediates CMO,Award, ... and drug product,facility, despite the current challenging economic environment. ... of Chemical,Development and is ready to help expand and ...
... It, Too! , , ATLANTA, June 3 We,ve all ... magazines ... celebrity moms flaunting their beautiful beach bodies in bikinis. ... which leaves the rest of us wondering how they got so ... trainer Susie Shina gained weight after having kids. The extra pounds ...
... 3 Gene Network Sciences, Inc. (GNS) today announced ... The University of Connecticut Health Center,s Carole ... parties will incorporate genetic, genomic and clinical data ("3-D ... be used to identify the best treatments for individual ...
... MINNEAPOLIS, June 3 ATS Medical, Inc. (Nasdaq: ... surgery products and services, today announced participation in the ... Meeting in San Francisco on June 3-6, 2009. ... surgeons from around the world whose interests include the ...
... ... , ... (Vocus) June 3, 2009 -- Morehead Associates will host a webinar on ... , ,Retaining skilled, engaged physicians is critical to the success of health systems across ...
... ... products and other services. , ... San Jose, Calif. (PRWEB) June 3, 2009 -- The Glowan Consulting Group, ... a new on-line store allowing clients and partners to purchase their suite of Leadership ...
Cached Medicine News:Health News:Asymchem Continues to Maintain a Good Running Posture, Despite Economic Crisis 2Health News:Asymchem Continues to Maintain a Good Running Posture, Despite Economic Crisis 3Health News:Asymchem Continues to Maintain a Good Running Posture, Despite Economic Crisis 4Health News:Celebrity Moms Make Headlines in Their New Bikinis 2Health News:Gene Network Sciences Announces Cancer Collaboration with University of Connecticut Health Center's Neag Comprehensive Cancer Center 2Health News:Gene Network Sciences Announces Cancer Collaboration with University of Connecticut Health Center's Neag Comprehensive Cancer Center 3Health News:ATS Medical Announces Participation in the International Society for Minimally Invasive Cardiothoracic Surgery Meeting 2Health News:ATS Medical Announces Participation in the International Society for Minimally Invasive Cardiothoracic Surgery Meeting 3Health News:ATS Medical Announces Participation in the International Society for Minimally Invasive Cardiothoracic Surgery Meeting 4Health News:Morehead Webinar on Driving Physician Retention through Engagement 2Health News:Glowan Consulting Announces New On-Line E-Commerce Site 2
(Date:7/25/2014)... , July 25, 2014 GrowBLOX Sciences, Inc. (OTCQB: ... Memorandum of Understanding ("MOU") with LaurelCo, LLC, an ... acquisition of both cultivation and dispensary medical marijuana licenses in ... the MOU, GBLX will acquire a 20% equity interest in ... GrowBLOX TM growing chambers, as well as all technology ...
(Date:7/25/2014)... , July 25, 2014  Acsis Inc., the ... and serialization solutions, has recently posted an article, ... addresses current and future needs for companies, extended ... old supply chain model no longer work today.  ... including the growth of mobile technology, machine to ...
(Date:7/25/2014)... MEXICO CITY , July 25, 2014 ... a Latin American healthcare sciences publisher, launched a library ... on conditions such as cancer and heart disease. Healthcare ... most up-to-date information to deliver better patient care. ... rapidly, with many relying on smartphones and tablets to ...
Breaking Medicine Technology:GrowBLOX Sciences, Inc. Partners with LaurelCo, LLC to Obtain Licenses to Cultivate and Dispense Medical Marijuana in Illinois 2GrowBLOX Sciences, Inc. Partners with LaurelCo, LLC to Obtain Licenses to Cultivate and Dispense Medical Marijuana in Illinois 3Acsis Addresses Questions on the Modern Supply Chain 2Healthcare Sciences Publisher PLM and IBM Speed Access to Medical Information to Deliver Better Patient Care with Mobile 2Healthcare Sciences Publisher PLM and IBM Speed Access to Medical Information to Deliver Better Patient Care with Mobile 3Healthcare Sciences Publisher PLM and IBM Speed Access to Medical Information to Deliver Better Patient Care with Mobile 4
... study presented at the American Association of Physicists in Medicine ... showed that 18FDG dose for Positron Emission Mammography (PEM) may ... quality. PEM scanners are high-resolution breast PET systems ... of a lesion.  The metabolic view assists physicians to make ...
... Aug. 23 Encorium Group, Inc. (Nasdaq: ENCO ... studies in over 30 countries for many of the world,s ... to commence a rights offering for up to 3,401,151 shares ... offering, each stockholder of record as of August 11, 2010 ...
Cached Medicine Technology:Preliminary Research Results Suggest up to 70% Reduction in Dose for Positron Emission Mammography Imaging 2Preliminary Research Results Suggest up to 70% Reduction in Dose for Positron Emission Mammography Imaging 3Encorium Group, Inc. Announces Terms of Proposed Rights Offering 2Encorium Group, Inc. Announces Terms of Proposed Rights Offering 3Encorium Group, Inc. Announces Terms of Proposed Rights Offering 4
Use the Mo Bio Vortex Adapter in conjunction with the Vortex Genie 2 for rapid bead beating procedures. Using the Mo Bio Vortex Adapter is an inexpensive alternative to other bead beating and Fast Pr...
... Combines BchiVac V-500, water-cooled secondary condenser ... housing Model V-500 is a powerful PTFE ... vacuum applications. Applications Ideally ... rotary evaporators Laboratory vacuum source ...
... secondary condenser to trap residual solvent vapors ... vacuum pump designed to handle most vacuum ... for use with up to two rotary ... instruments including vacuum ovens, concentrators, gel dryers, ...
Universal vacuum pump (capacity 34 L/min, 8 mbar vacuum abs.)...
Medicine Products: